Southernsun Asset Management Has Trimmed Clean Harbors (CLH) Position; Biohaven Pharmaceutical Holding (BHVN) Shorts Raised By 3.04%

December 7, 2017 - By Henry Gaston

Southernsun Asset Management Llc decreased Clean Harbors Inc. (CLH) stake by 1.03% reported in 2017Q2 SEC filing. Southernsun Asset Management Llc sold 37,437 shares as Clean Harbors Inc. (CLH)’s stock rose 3.54%. The Southernsun Asset Management Llc holds 3.59M shares with $200.38 million value, down from 3.63 million last quarter. Clean Harbors Inc. now has $3.03B valuation. The stock decreased 0.67% or $0.36 during the last trading session, reaching $53.15. About 347,561 shares traded or 15.00% up from the average. Clean Harbors, Inc. (NYSE:CLH) has risen 18.53% since December 7, 2016 and is uptrending. It has outperformed by 1.83% the S&P500.

Biohaven Pharmaceutical Holding (NYSE:BHVN) had an increase of 3.04% in short interest. BHVN’s SI was 2.05 million shares in December as released by FINRA. Its up 3.04% from 1.99M shares previously. With 177,700 avg volume, 12 days are for Biohaven Pharmaceutical Holding (NYSE:BHVN)’s short sellers to cover BHVN’s short positions. The stock decreased 3.13% or $0.66 during the last trading session, reaching $20.44. About 378,844 shares traded or 43.09% up from the average. Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) has 0.00% since December 7, 2016 and is . It has underperformed by 16.70% the S&P500.

Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops product candidates to treat neurological diseases, including rare disorders. The company has market cap of $736.20 million. The Company’s advanced product candidate includes rimegepant, which is intended to initiate two Phase III clinical trials for the acute treatment of migraine; and trigriluzole, which is in a Phase II/III clinical trial used for the treatment of ataxias with an initial focus on spinocerebellar ataxia. It currently has negative earnings. The firm also develops BHV-3500 for the prevention of chronic and episodic migraine; BHV-0223 for the treatment of amyotrophic lateral sclerosis, a neurodegenerative disease that affects nerve cells in the brain and spinal cord; and BHV-5000 for the treatment of symptoms associated with Rett syndrome, such as breathing irregularities.

Investors sentiment increased to 1.22 in 2017 Q2. Its up 0.02, from 1.2 in 2017Q1. It is positive, as 16 investors sold CLH shares while 69 reduced holdings. 30 funds opened positions while 74 raised stakes. 53.18 million shares or 1.96% less from 54.24 million shares in 2017Q1 were reported. Jp Marvel Inv Advisors Limited Liability Company has invested 0.35% in Clean Harbors, Inc. (NYSE:CLH). Yhb Advsr reported 28,726 shares stake. Aqr Cap Mgmt Ltd Liability holds 0% of its portfolio in Clean Harbors, Inc. (NYSE:CLH) for 35,550 shares. 106,554 were accumulated by American. Moreover, Asset Mgmt One Ltd has 0% invested in Clean Harbors, Inc. (NYSE:CLH) for 3,640 shares. Utah Retirement holds 9,600 shares. Whittier Tru holds 0% of its portfolio in Clean Harbors, Inc. (NYSE:CLH) for 435 shares. Voya Investment Mngmt Ltd Llc, Georgia-based fund reported 18,553 shares. 6,562 are held by Lpl Financial Ltd Liability. Sandler Capital Management accumulated 0.43% or 70,722 shares. New York State Common Retirement Fund invested in 258,611 shares. Thrivent Fincl For Lutherans reported 0% in Clean Harbors, Inc. (NYSE:CLH). World Asset Mngmt Inc owns 3,596 shares. Verition Fund Mgmt Limited Co holds 0.04% of its portfolio in Clean Harbors, Inc. (NYSE:CLH) for 7,335 shares. Credit Suisse Ag reported 0.02% of its portfolio in Clean Harbors, Inc. (NYSE:CLH).

Among 14 analysts covering Clean Harbors Inc. (NYSE:CLH), 6 have Buy rating, 0 Sell and 8 Hold. Therefore 43% are positive. Clean Harbors Inc. had 36 analyst reports since July 27, 2015 according to SRatingsIntel. The company was maintained on Wednesday, August 30 by Needham. Barclays Capital downgraded the stock to “Underweight” rating in Tuesday, January 10 report. Needham maintained Clean Harbors, Inc. (NYSE:CLH) rating on Thursday, February 23. Needham has “Buy” rating and $61 target. As per Monday, August 7, the company rating was upgraded by Barclays Capital. Stifel Nicolaus maintained the stock with “Buy” rating in Monday, November 14 report. On Wednesday, May 18 the stock rating was initiated by Barclays Capital with “Overweight”. BMO Capital Markets maintained Clean Harbors, Inc. (NYSE:CLH) on Thursday, November 2 with “Outperform” rating. The rating was upgraded by KeyBanc Capital Markets to “Overweight” on Tuesday, January 31. Oppenheimer upgraded Clean Harbors, Inc. (NYSE:CLH) on Thursday, March 16 to “Outperform” rating. The company was maintained on Thursday, November 5 by Imperial Capital.

Southernsun Asset Management Llc increased Aegion Corp. (NASDAQ:AEGN) stake by 169,122 shares to 1.08M valued at $23.70M in 2017Q2. It also upped Western Union Co. (NYSE:WU) stake by 829,507 shares and now owns 7.54 million shares. Timken Co. (NYSE:TKR) was raised too.

Analysts await Clean Harbors, Inc. (NYSE:CLH) to report earnings on February, 28. They expect $0.06 EPS, up 200.00% or $0.12 from last year’s $-0.06 per share. CLH’s profit will be $3.42M for 221.46 P/E if the $0.06 EPS becomes a reality. After $0.21 actual EPS reported by Clean Harbors, Inc. for the previous quarter, Wall Street now forecasts -71.43% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.